Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

1. Denner is positioning not on Mkt Caps or Revs but more so on an intrinsic value that is not based on pure numbers. He is or will pitch Ariad as a known entity that has developed drugs as a skilled team with experience and success. That is so valuable to a big drug company especially if it is filling a void in their own ability and pipeline. Denner's job is finding that niche and then presenting in a way to maximize return. He has done it before and IMHO he will do it with this company.

2. Hopefully, a bidding war of sorts will break out where there is 2 or more interested parties as the news comes out. Based on little news in the past many months, Denner is holding his cards close and wanting to play them for all they are worth. He knows that he has one shot at it and is the person to get results based on past experience and performance. This is a pro at the highest level who will be running and holding the auction.

3. I think that the hedge funds will be looking at least 4-5 times their acquisition pps level. Also, Ariad had a history of the mid-twenties before mismanagement led us to this level.

Many may disagree with this analysis but it is my best shot at what I think will happen in time. The holes are not per se with the logic but rather with the absolute numbers. At this point, Denner in selling the company is an artist/engineer/salesman not a logical scientist. In a nutshell, the buyout price is not all about logic but rather what some company is willing to pay based on need and potential not just a future revenue level. With that I absolutely respect your approach and it always could go for less.....that's just not what I think at this point. Thanks to you too. With respect.

--not based on real numbers
--hopefully..
--I think

I do not think this is how the market works..